Jakob M. Riedl

Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer

Florian Posch, Karīna Siliņa, Sebastian Leibl et al. · OncoImmunology · 2017 · 368 citations · Full text

Medicine, Oncology, Pathology +17

The width of resection margins influences local recurrence in soft tissue sarcoma patients

V. Kainhofer, Maria Anna Smolle, Joanna Szkandera et al. · European Journal of Surgical Oncology · 2016 · 106 citations

Medicine, Oncology, Surgery +15

C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study

Jakob M. Riedl, Dominik A. Barth, Wolfgang M. Brueckl et al. · Cancers · 2020 · 105 citations · Full text

Medicine, Immunology, Oncology +17

The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: <i>post hoc</i> analysis of an Austrian multicenter, noninterventional study

Jakob M. Riedl, Florian Posch, Gerald W. Prager et al. · Therapeutic Advances in Medical Oncology · 2020 · 63 citations · Full text

Medicine, Oncology, Pharmacology +16

Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis

Jakob M. Riedl, Florian Posch, Lena Horvath et al. · European Journal of Cancer · 2021 · 58 citations · Full text

Medicine, Oncology, Pharmacology +9